Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism

OBJECTIVE: Structurally-improved GIP analogs were developed to determine precisely whether GIP receptor (GIPR) agonism or antagonism lowers body weight in obese mice. METHODS: A series of peptide-based GIP analogs, including structurally diverse agonists and a long-acting antagonist, were generated...

Descripción completa

Detalles Bibliográficos
Autores principales: Mroz, Piotr A., Finan, Brian, Gelfanov, Vasily, Yang, Bin, Tschöp, Matthias H., DiMarchi, Richard D., Perez-Tilve, Diego
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358549/
https://www.ncbi.nlm.nih.gov/pubmed/30578168
http://dx.doi.org/10.1016/j.molmet.2018.12.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358549/
https://www.ncbi.nlm.nih.gov/pubmed/30578168
http://dx.doi.org/10.1016/j.molmet.2018.12.001

Ejemplares similares